Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U.S. At-the-Market Offering Program
18.02.2022 - Orphazyme A/SCompany announcementNo. 06/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 18, 2022 – Orphazyme A/S (ORPHA.CO (DK); ORPH (US)) (the “Company”), a late-stage biopharmaceutical company, announces ... Seite 1
Anders Vadsholt Articles Of Association Company Board Of Directors Company Us Offering Program Company Articles Of Association Market Offering Program
Source: wallstreet-online.de